Literature DB >> 1236781

Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus.

W F Clark, M L Lewis, J S Cameron, V Parsons.   

Abstract

1. Platelet survival and an index of the localization of platelets in the kidney were studied in patients with the proliferative nephritis of systemic lupus erythematosus, either focal or diffuse, and in control subjects. Platelet survival was reduced in patients with proliferative lupus nephritis, more in those with diffuse rather than focal renal involvement. 2. The index of renal platelet localization in patients with diffuse proliferative nephritis suggested an intrarenal platelet consumption not found in other groups. 3. A patient with the classical platelet autoantibody disease, idiopathic thrombocytopenic purpura, also showed reduced platelet survival but localization of platelets was in the spleen rather than the kidney. 4. Intrarenal platelet consumption in diffuse proliferative lupus nephritis may be an epiphenomenon of pre-existing scarring or platelet aggregation secondary to immune complex-formation, which contributes to the progressive sclerosing lesions of this form of nephritis.

Entities:  

Mesh:

Year:  1975        PMID: 1236781     DOI: 10.1042/cs0490247

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  3 in total

1.  Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.

Authors:  W F Clark; A L Linton; P E Cordy; P E Keown; R C Lohmann; R M Lindsay
Journal:  Can Med Assoc J       Date:  1978-06-10       Impact factor: 8.262

2.  Focal mesangial proliferative glomerulonephritis in the rat caused by Habu snake venom: the role of platelets.

Authors:  V Cattell
Journal:  Br J Exp Pathol       Date:  1979-04

3.  Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.

Authors:  E Weissbarth; B Baruth; H Mielke; W Liman; H Deicher
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.